The functional role of these cytokines in immune responses, as well as the established utility of CRP and SAA as biomarkers of cardiometabolic disease risk [9,10], suggest clinically relevant consequences of these observed race-differences in response to endotoxemia. This evidence concerns the gene CRP and serum lipopolysaccharide activity.